अApnaFunda
Menu

Medplus Health Services vs Nephrocare Health Serv

Both in Drugstore Chains · as of 9 Nov · Methodology

MEDPLUSNEPHROPLUSChange the comparison →
At a glanceNov 2026
MEDPLUSNEPHROPLUSROCE13.0%15.0%Operating margin7.0%21.0%P/E34.0x148.0xDebt / Equity0.7x0.1x
Highlight: the higher value, or the lower for P/E and debt.Full snapshot →

Where the return came from

Price change over 3 years, split into profit, share count and P/E.

MEDPLUS Net profit growth: +125 pts+125 ptsShare count change: -0 ptsP/E change: -150 pts-150 pts -25% MEDPLUS Net profit growth: +125 pts+125 ptsShare count change: -0 ptsP/E change: -150 pts-150 pts -25%
Net profit growthShare count changeP/E changeUnexplained
PointsPriceProfitSharesP/E
MEDPLUS-25%+1250−150

Not shown for NEPHROPLUS: earnings were negative at one end of the window or there is not enough history.

Rank within sector

Percentile among sector peers, by month. Rows marked ↓ rank lower values higher.

Medplus Health ServicesRetail Trade
ROCE
Op. margin
Revenue growth
EPS growth
Debt/equity ↓
Cash cycle ↓
P/E ↓
12M momentum
Dec '21202320242025Nov '26
Lower rank Higher rank Not enough data
Nephrocare Health ServRetail Trade
ROCE
Op. margin
Debt/equity ↓
Cash cycle ↓
P/E ↓
Dec '21202320242025Nov '26
Lower rank Higher rank Not enough data

Snapshot

Share price: close of 9 Nov; other figures: latest month, Nov 2026.

MetricMEDPLUSNEPHROPLUS
Size and price
Share Price₹596.00₹620.05
Market Cap₹7160 cr₹6231 cr
Revenue (TTM)₹7229 cr₹1054 cr
Net Profit (TTM)₹211 cr₹85 cr
Valuation
P/E34.0x148.0x
P/B3.6x5.6x
P/S1.0x5.9x
Profitability
ROCE13.0%15.0%
ROE10.7%3.8%
Operating margin7.0%21.0%
MetricMEDPLUSNEPHROPLUS
Balance sheet and cash
Debt / Equity0.7x0.1x
Interest cover3.1x3.0x
Cash conversion (3Y)2.7x2.5x
Cash Conversion Cycle79d116d
Ownership
Promoter holding40.2%63.9%
FII Holding14.4%8.8%
DII Holding29.9%9.1%
Share Count Change (1Y)0.0%—
Price behaviour
12M momentum-26.3%—
Drawdown from Peak-45.1%-9.2%
Volatility (1Y)29.7%40.1%
Open all in the observatory →Retail Trade sector →

Comparison is descriptive and historical. Highlights mark the higher or lower value on a metric, not a better investment.

Methodology

How comparisons are computed

Definitions and known limitations.

Data and timing

Every figure is a monthly, point-in-time value: fundamentals join a month only 60 days after the quarter ends, so a month never shows a result that would not yet have been published. The numbers are the same ones each company's own page shows.

Share price

Monthly closes, rebased to 100 at the first month every company in the comparison has a price. A company listed later moves the start of the chart for all of them.

Metrics over time

Months with a missing value are left as gaps. On a log scale, equal vertical distances are equal ratios, and months with a non-positive value are gaps too. Revenue is indexed to 100 at the first month every company has a positive figure.

Where the return came from

Price = P/E × net profit ÷ share count, so a price return splits into percentage points from net profit growth, share count change and the change in P/E. It is not shown for a company whose earnings were negative at one end of the window.

Rank within sector

Each cell is the company's percentile rank among its own sector's companies that month. Rows marked ↓ are inverted: lower debt, a shorter cash cycle and a lower P/E rank higher. Ranks use today's listed companies in the sector and need at least 5 peers with a value. Banks and financial companies are ranked on a different set of metrics, so their blocks show different rows.

Highlights

A highlight marks the higher value, or the lower value for P/E, P/B, P/S, debt, working-capital days, share count change and volatility. It marks a number, not a better investment. P/E, P/B and P/S only count when positive.

Feedback